ARCUS BIOSCIENCES INC (RCUS)

US03969F1093 - Common Stock

15.545  +0.31 (+2.07%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to RCUS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 39.98. This target is 157.21% above the current price.
RCUS was analyzed by 18 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RCUS.
In the previous month the buy percentage consensus was at a similar level.
RCUS was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 15.5524.2437.2339.9873.50 - 55.93% 139.50% 157.21% 372.82%
Up and Down Grades
Date Firm Action Rating
2024-03-25 Truist Securities Reiterate Buy -> Buy
2024-02-22 Wedbush Reiterate Outperform -> Outperform
2024-01-30 Mizuho Maintains Buy -> Buy
2024-01-30 Wedbush Maintains Outperform -> Outperform
2024-01-17 Wedbush Reiterate Outperform -> Outperform
2023-11-13 Morgan Stanley Maintains Overweight -> Overweight
2023-11-08 Cantor Fitzgerald Maintains Overweight -> Overweight
2023-10-03 Mizuho Reiterate Buy -> Buy
2023-09-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-06 Truist Securities Reiterate Buy -> Buy
2023-09-05 B of A Securities Maintains Neutral -> Neutral
2023-08-24 Citigroup Maintains Buy -> Buy
2023-08-23 Mizuho Reiterate Buy -> Buy
2023-08-23 BTIG Reiterate Buy -> Buy
2023-08-08 Morgan Stanley Maintains Overweight -> Overweight
2023-07-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-05-26 Citigroup Maintains Buy -> Buy
2023-05-10 Wedbush Reiterate Outperform
2023-03-17 Mizuho Reiterate Buy
2022-12-21 Barclays Maintains Overweight
2022-12-20 Citigroup Maintains Buy
2022-11-23 Citigroup Maintains Buy
2022-11-18 B of A Securities Initiate Neutral
2022-11-03 SVB Leerink Maintains Outperform
2022-10-11 Morgan Stanley Initiate Overweight
2022-08-04 SVB Leerink Maintains Outperform
2022-07-08 Truist Securities Maintains Buy
2022-05-12 Goldman Sachs Maintains Neutral
2022-05-11 Goldman Sachs Maintains Neutral